UroGen Pharma to Present at Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Aug 21, 2025
PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in September.
Read more at globenewswire.com
